Masafumi Ikeda
Hepatobiliary and Pancreatic Oncology Division
National Cancer Center Hospital
Tokyo
Japan
Name/email consistency: high
- Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis. Ikeda, M., Okusaka, T., Ueno, H., Morizane, C., Iwasa, S., Hagihara, A., Kojima, Y. Oncology (2007)
- A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer. Ikeda, M., Okusaka, T., Ito, Y., Ueno, H., Morizane, C., Furuse, J., Ishii, H., Kawashima, M., Kagami, Y., Ikeda, H. Br. J. Cancer (2007)
- A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma. Ikeda, M., Okusaka, T., Ueno, H., Takezako, Y., Morizane, C. Cancer (2005)
- A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma. Ikeda, M., Okusaka, T., Ueno, H., Morizane, C., Furuse, J., Ishii, H. Jpn. J. Clin. Oncol. (2005)
- Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Ikeda, M., Maeda, S., Shibata, J., Muta, R., Ashihara, H., Tanaka, M., Fujiyama, S., Tomita, K. Oncology (2004)









